Patexia Insight - IPR Intelligence Report (2020 Edition)
Transcript of Patexia Insight - IPR Intelligence Report (2020 Edition)
INSIGHTS
DATA ANALYSIS
DATA CLEANUP
DATA COLECTION
Prepared ByPatexia Data Science Team
Patexia. Insights
A comprehensive report on the top 100 best TIVJSVQMRK�ERH�QSWX�EGXMZI�-46�EXXSVRI]W�ERH�PE[�ƤVQW�
SEPTEMBER 2020
IPRIntelligence ReportJULY 2015 / JUNE 2020
2020 EDITION
2
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Table of ContentsIntroduction 5
What is New in Our 4th Report? 5
What’s in This Report? 8
Executive Summary 9
Section 1 - Ranking Methodology 10
Changes and Improvements to Our Ranking Methodology since 2019 11Success Scores for Petitioners, Patent Owners and Overall 13Activity Scores for Petitioners, Patent Owners and Overall 14Performance Scores for Petitioners, Patent Owners and Overall 14Performance and Activity Rankings for Petitioners, Patent Owners and Overall 15Performance of Judges 15
Section 2 - IPR Staffing and Cost 16
7XEJƤRK 18Cost Analysis 20Attorney Fees 22Expert Cost 32Hourly Rates of Attorneys 33Other Key Factors Driving the Cost of IPR 35
Section 3 - IPR Statistics 36
YoY Comparison of IPR Filings (Case, Patent, and Claim Levels) 38Most Popular IPC Codes 41By the Numbers: Judges, Law Firms, Petitioners, and Patent Owners 42
3
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Section 4 - IPR Denial and Invalidation Analysis by Technology Area 43
Case-Level Status as Reported by the USPTO 44YoY Comparison of FWD Entered, Settlement, and Denial Rates 46Top 10 IPC Codes for Patents with Denial or Settlement Decision 48Top 10 IPC Codes for Patents with Final Written Decisions 50
Section 5 - Performanceof the PTABJudges 52
10 Most Active PTAB Judges 54Top 10 Judges with the Highest Number of Invalidated Claims 55Performance of PTAB Administrative Judges 56
Section 6 - Performance of the Petitioners and Patent Owners 64
The Most Active Petitioners and Patent Owners 65Top 100 Most Active Companies in IPR 66Top 100 Best Performing Petitioners and Patent Owners 71
Section 7 - Performance of the Law Firms 78
Most Active Law Firms in IPR 80Top 100 Best Performing Law Firms in IPR 87
Section 8 - Performance of Attorneys 94
Most Active Attorneys in IPR 96Top 100 Most Active Attorneys 96Top 100 Best Performing Attorneys 107
4
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Appendix 117
Appendix A - Sources of Data 118
Appendix B - Patent Owners and Petitioners Statistics 119
Appendix C - Law Firms Statistics 120
Appendix D - Attorneys Statistics 121
Appendix E - Survey Questions 122
Contact Us 128
Our Products 129
5
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
IntroductionThis September marks the eighth year WMRGI�XLI�ƤVWX�-RXIV�4EVXIW�6IZMI[��-46 �TIXMXMSR�[EW�ƤPIH��%JXIV�MXW�MRGITXMSR�SR�7ITXIQFIV���XL��������-46�KEMRIH�TSTYPEV�MX]�IZIV]�]IEV�ERH�UYMGOP]�FIGEQI�TEVX�SJ�XLI�HIJIRWI�WXVEXIK]�YXMPM^IH�F]�HIJIRHERXW�MR�TEXIRX�PMXMKEXMSR��
8LI�-46�ƤPMRK�EGXMZMX]�VIEGLIH�MXW�TIEO�MR������[MXL�E�XSXEP�SJ�������TIXMXMSRW��-R�������[I�WE[�E�QSHIVEXI�HIGPMRI�SJ�WIZIR�TIV�GIRX�JSPPS[IH�F]�E�[LSTTMRK�HIGPMRI�SJ����TIVGIRX�PEWX�]IEV��[LMGL�[EW�MR�PMRI�[MXL�XLI�HVST�MR�TEXIRX�PE[WYMXW�MR�VIGIRX�]IEVW�
%GGSVHMRK�XS�SYV�HEXE���XLIVI�[EW�ER�YTXMGO�MR�ƤPMRK�EGXMZMX]�XS[EVHW�XLI�IRH�SJ�������
ERH�XLMW�EGGIPIVEXIH�MR�XLI�ƤVWX�LEPJ�SJ�������-R�JEGX��HYVMRK�XLI�WIGSRH�UYEVXIV�IRHIH�SR�.YRI�����-46�ƤPMRK�VSWI����TIV�GIRX��GSQTEVIH�XS�XLI�ƤVWX�UYEVXIV�SJ�������4EXIRX�PMXMKEXMSR�EPWS�VSWI����TIVGIRX�MR�5���4EXI\ME�-RWMKLX��� ��
;MXL�������-46�TIXMXMSRW�ƤPIH�SZIV�XLI�PEWX�ƤZI�]IEVW��.YP]���������XLVSYKL�.YRI��������� ��-46�LEW�KEMRIH�E�GSRWMHIVEFPI�QEVOIX�WM^I��%W�E�VIWYPX��XLI�QENSVMX]�SJ�%Q�0E[�����ƤVQW�[MXL�E�VSFYWX�-4�TVEGXMGI�LEZI�EPVIEH]�JSVQIH�E�48%&��Patent Trial and Appeal Board �TVEGXMGI��%PWS��SZIV�XLI�PEWX�JI[�]IEVW��[I�LEZI�WIIR�WIZIVEP�WQEPP�-4�FSYXMUYIW�JSVQMRK�[MXL�E�JSGYW�SR�-46�ERH�48%&�[SVO��
What is New in Our 4th Report?
;I�LEZI�QEHI�E�RYQFIV�SJ�MQTVSZIQIRXW�XS�XLMW�]IEVŭW�VITSVX�EX�XLI�WYKKIWXMSR�SJ�SYV�GSQQYRMX]��ERH�[I�EVI�GSRƤHIRX�]SY�[MPP�WII�XLI�EHHIH�ZEPYI�MR�XLIWI�GLERKIW�
3RI�SJ�XLI�OI]�UYIWXMSRW�GSQTERMIW�[SYPH�PMOI�XS�ORS[�MW�XLI�IWXMQEXIH�GSWX�SJ�ER�-46�ERH�TSXIRXMEP�GSWX�MJ�XLI�GEWI�MW�WIXXPIH�EX�HMJJIVIRX�TLEWIW��8LMW�MRJSVQEXMSR�MW�EPWS�ZIV]�ZEPYEFPI�XS�PE[�ƤVQW�EW�XLI]�[SYPH�PMOI�XS�ORS[�LS[�XLIMV�TVMGMRK�QSHIP�WXEGOW�YT�
EKEMRWX�SXLIV�ƤVQW��8S�ERW[IV�XLIWI�UYIW�XMSRW��[I�GSRHYGXIH�E�WYVZI]�ERH�EWOIH�-46�EXXSVRI]W�XS�LIPT�YW�IWXMQEXI�XLI�-46�GSWX�MR���HMJJIVIRX�TLEWIW�EW�LMKLPMKLXIH�ERH�I\TPEMRIH�MR�7IGXMSR����
;I�EPWS�EXXIQTXIH�XS�IWXMQEXI�ERH�ƤRH�SYX�XLI�[SVOPSEH�ERH�WXEJƤRK�JSV�X]TMGEP�-46�GEWIW�XS�LIPT�PE[�ƤVQW�GSQTEVI�XLIQ�WIPZIW�[MXL�SXLIV�ƤVQW�
6
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
%RSXLIV�WMKRMƤGERX�YTHEXI�[EW�MR�SYV�VEROMRK�QIXLSHSPSK]��-R�SYV�TVIZMSYW�VITSVXW��[I�QIEWYVIH�ERH�VEROIH�EXXSVRI]W�F]�EGXMZMX]�ERH�WYGGIWW��[I�GEPPIH�MX�TIV�JSVQERGI ��,S[IZIV��[I�YRHIVWXERH�XLEX�PEVKI�GEWI�RYQFIVW�[SYPH�MRIZMXEFP]�HMPYXI�TIVJSVQERGI�SZIV�XMQI��EJXIV�EPP��RSRI�SJ�YW�GER�IWGETI�XLI�PE[�SJ�EZIVEKIW� ��8LMW�QEOIW�MX�YRMHIEP�XS�GSQTEVI�XLI�TIVJSV�QERGI�WGSVIW�SJ�ƤVQW�EXXSVRI]W�[MXL�ZIV]�HMJJIVIRX�GEWI�PSEHW��IZIR�XLSYKL�[I�LEZI�E�GYX�SJJ�XLVIWLSPH�[LMGL�[I�YWI�XS�I\GPYHI�PE[�ƤVQW�SV�EXXSVRI]W�[MXL�ZIV]�WQEPP�GEWI�PSEH ��&]�XEOMRK�XLIWI�GSRWMHIVEXMSRW�MRXS�EGGSYRX��[I�GVIEXIH�E�RI[�“Performance Score”�ERH�“Performance Ranking”��[LMGL�EPPS[�YW�XS�WGSVI�ERH�VERO�GSQTERMIW��EX�XSVRI]W��ERH�ƤVQW�JSV�FSXL�Activity and Suc-cess�GSQFMRIH��-R�SXLIV�[SVHW��XLMW�RI[�TIVJSVQERGI�WGSVI�MW�E�[IMKLXIH�EZIVEKI�SJ�Success�ERH�Activity�WGSVIW��8LMW�RI[�TIVJSVQERGI�VEROMRK�LIPTW�GSQTERMIW�ƤRH�XLI�LMKLP]�EGXMZI�ERH�LMKLP]�WYGGIWWJYP�PE[�ƤVQW�ERH�EXXSVRI]W��M�I���XLI�QSWX�UYEPMƤIH�SRIW ��
%RSXLIV�GLERKI�[I�QEHI�MR�XLMW�VITSVX��[EW�SR�EPPSGEXMRK�TSMRXW�JSV�WIXXPIH�GEWIW��-R�XLI�TEWX�XLVII�VITSVXW��[I�KEZI�EPP�XLI�TSMRXW�XS�XLI�TIXMXMSRIV�EW�XLI�EWWYQTXMSR�[EW�XLEX�XLI�TEXIRX�S[RIV�EKVIIH�XS�WIXXPI�XS�GYX�MXW�PSWWIW��&YX�EW�QER]�SJ�SYV�WYVZI]�VIWTSR�HIRXW�MRHMGEXIH��XLMW�QMKLX�RSX�EP[E]W�FI�XLI�GEWI��%W�E�VIWYPX��[I�HIGMHIH�XS�HMZMHI�XLI�
TSMRX�������FIX[IIR�XLI�TIXMXMSRIV�ERH�XLI�TEXIRX�S[RIV��SYV�EWWYQTXMSR�MW�XLEX�WIXXPI�QIRX�MW�E�FIXXIV�SYXGSQI�JSV�XLI�TIXMXMSRIV �
;I�EPWS�MQTVSZIH�SYV�HEXE�UYEPMX]�F]�KMZMRK�HMVIGX�EGGIWW�XS�EXXSVRI]W�XS�VIZMI[�ERH�ZIVMJ]�XLIMV�GEWIW�SR�4EXI\ME�[IFWMXI��)EGL�-46�EXXSVRI]�[EW�GSRXEGXIH�ERH�TVSZMHIH�E�YRMUYI�PMRO�F]�SYV�WXEJJ�XS�PSKMR�ERH�EGGIWW�XLIMV�GEWIW��3YV�HEXE�EREP]WXW�XLIR�VI�ZMI[IH�EPP�XLI�GLERKIW�WYKKIWXIH�F]�XLI�EX�XSVRI]W�XS�QEOI�WYVI�XLI]�GSVVIGXP]�QEXGL�[MXL�TYFPMG�VIGSVHW�EZEMPEFPI�XLVSYKL�48%&��
%W�[I�GSRXMRYI�TYFPMWLMRK�XLIWI�ERRYEP�VITSVXW��[I�XV]�XS�MQTVSZI�XLI�EGGYVEG]��VE[�HEXE ��QSHIPW��ERH�XLI�VITSVX�GSRXIRX��X]TI�SJ�EREP]WIW �IEGL�]IEV��1SVISZIV��[I�LEZI�I\TERHIH�SYV�SJJIVMRKW�XS�GSZIV�SXLIV�EVIEW�SJ�-4�WYGL�EW�Patent Prosecution, ITC Section 337, ANDA/Hatch-Waxman�ERH�4EXIRX�0MXMKEXMSR�
;I�GSRWMHIV�EPP�XLI�JIIHFEGO�[I�VIGIMZI�JVSQ�XLI�-4�GSQQYRMX]�XS�MQTVSZI�ERH�QEOI�XLI�VITSVXW�QSVI�YWIJYP�XS�IZIV]�FSH]��MRGPYHMRK�SYV�PE[�ƤVQ�ERH�GSVTSVEXI�TEVXRIVW��3YV�EREP]WMW�LEW�FIGSQI�QSVI�GSQTPI\�ERH�GSZIVW�E�[MHIV�VERKI�XLER�MR�XLI�TEWX��
8LMW�]IEV��MR�VIWTSRWI�XS�SYV�GSQQYRMX]�VIUYIWX��[I�LEZI�MRGVIEWIH�SYV�GSZIVEKI�SJ�PE[�ƤVQW��EXXSVRI]W�ERH�GSQTERMIW�XS�
7
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
XLI�XST�������QSWX�EGXMZI��YT�JVSQ�����MR�TVMSV�]IEVW ��;LMPI�FIMRK�MR�XLI�XST�����MR�E�VIWTIGXIH�GEXIKSV]�MW�E�WMKRMƤGERX�EGGSQ�TPMWLQIRX��EW�MX�TYXW�XLI�EXXSVRI]�MR�XLI�XST�X[S�TIVGIRXMPI��XLI�PE[�ƤVQ�MR�XLI�XST����TIVGIRXMPI�ERH�XLI�GSQTER]�MR�EPQSWX�XLI�XST�XLVII�TIVGIRXMPI��ORS[PIHKI�EFSYX�XLI�VIQEMRMRK�TEVXMGMTERXW�MW�UYMXI�MQTSVXERX�ERH�YWIJYP�EW�[IPP��;I�EPWS�LEZI�TVSZMHIH�XLI�EHHMXMSREP�HEXE�MR�XLI�EGGSQTER]MRK�)\GIP�ƤPI��
8LMW�YTHEXI�[EW�HSRI�FIGEYWI�QER]�GSVTSVEXI�GPMIRXW�[LS�HMH�RSX�ƤRH�XLIMV�-46�GSYRWIP�MR�XLI�XST������[IVI�MRXIVIWXIH�XS�ORS[�EFSYX�XLIMV�TIVJSVQERGI��ERH�XLI]�MR�UYMVIH�EFSYX�MX�EJXIV�TYVGLEWMRK�XLI�VITSVX��
;I�LSTI�XLEX�SYV�GSVTSVEXI�ERH�PE[�ƤVQ�GPMIRXW�ƤRH�XLMW�VITSVX�YWIJYP�ERH�YWI�MX�IJJIGXMZIP]�JSV�IMXLIV�GSYRWIP�WIPIGXMSR��GSVTSVEXMSR �SV�FYWMRIWW�HIZIPSTQIRX��PE[�ƤVQW �
Founder and CEOSeptember 2020
8
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
8LI�VITSVX�GSRXIRX�LEW�FIIR�HMZMHIH�MRXS�XLI�JSPPS[MRK�WIGXMSRW�
��ɄRanking Methodology:�;I�I\TPEMR�SYV�EGXMZMX]��WYGGIWW�ERH�TIVJSVQERGI�WGSVIW��ERH�LS[�[I�LEZI�GEPGYPEXIH�XLIQ�JSV�TEXIRX�S[RIVW��TIXMXMSRIVW��ERH�XLIMV�VITVIWIRXEXMZIW��EW�[IPP�EW�XLI�48%&�NYHKIW�
��Ʉ7XEJƤRK��'SWX�ERH�;SVOPSEH� We an�EP]^I�XLI�VIWYPX�SJ�SYV�WYVZI]��[LMGL�GSZIVIH�-46�WXEJƤRK��GSWX�IWXMQEXMSR�ERH�[SVOPSEH
��ɄIPR Statistics: ;I�TVSZMHI�ER�SZIVZMI[�SJ�-46�MRGPYHMRK�LMKL�PIZIP�WXEXMWXMGW�VIPEXIH�XS�EPP�TEVXMIW��GEWIW��TEXIRXW��ERH�GPEMQW�
��ɄCase Analysis: ;I�HMZI�MRXS�GEWI�PIZ�IP�WXEXMWXMGW�ERH�EREP]^I�Settlement, Denial, ERH�Invalidation�VEXIW��;I�EPWS�I\EQMRI�-4'�GSHIW�ERH�XLIMV�TSTYPEVMX]�MR�-46�
��ɄPTAB Administrative Judges: ;I�I\EQ�MRI�XLI�TIVJSVQERGI�SJ�EFSYX�����PTAB Administrative Judges��MHIRXMJ]MRK�XLI�QSWX�EGXMZI�EW�[IPP�EW�XLI�FIWX�TIVJSVQ�MRK�JVSQ�XLI�ZMI[TSMRX�SJ�Patent Owners or 4IXMXMSRIVW�
��ɄPetitioners and Patent Owners: ;I�MHIRXMJ]�XLI�QSWX�EGXMZI�ERH�XLI�FIWX�TIVJSVQMRK�Petitioners�ERH�Patent Owners SZIV�XLI�PEWX�ƤZI�]IEVW�
��ɄLaw Firms:�;I�EREP]^I�XLI�TIVJSVQERGI�ERH�EGXMZMX]�SJ�PE[�ƤVQW��GSQTEVMRK�ERH�TVSZMHMRK�VEROMRKW�JSV�XLI�XST�ƤVQW�VIT�resenting Petitioners�ERH�4EXIRX�3[RIVW�
��ɄAttorneys:�;I�VIZMI[�XLI�TIVJSVQERGI�ERH�EGXMZMX]�SJ�EXXSVRI]W��VITVIWIRXMRK�Petitioners�ERH�Patent Owners, com�TEVMRK�ERH�TVSZMHMRK�VEROMRKW�JSV�XST�EXXSVRI]W�SR�IEGL�WMHI�
%W�TIV�SYV�XVEHMXMSR�JSV�XLMW�ERH�SYV�SXLIV�MRXIPPMKIRGI�VITSVXW��ERH�MR�SVHIV�XS�LEZI�E�QIER�MRKJYP�GSQTEVMWSR��EW�[IPP�EW�GSQTIRWEXMRK�JSV�XLI�XMQI�VIUYMVIH�JSV�IEGL�GEWI�JVSQ�ƤPMRK�XS�GSQTPIXMSR��I�K�����XS����QSRXLW ��[I�GSZIVIH�E�TIVMSH�SJ�ƤZI�]IEVW��I�K���.YP]����������XLVSYKL�.YRI��������� ��%PXLSYKL�XLI�GYX�SJJ�HE]�JSV�GEWIW�[EW�.YRI�����������[I�YWIH�XLI�PEXIWX�YTHEXIW�JSV�XLI�GEWIW�EW�SJ�%YKYWX�����������%TTIRHM\�%�PMWXW�EPP�WSYVGIW�SJ�HEXE�YWIH�JSV�XLMW�VITSVX
What’s in This Report?
DISCLAIMER: The data for this report was obtained from public sources including USPTO, PTAB, and PACER, as well as WIPJ�VITSVXIH�F]�EXXSVRI]W�SR�4EXI\ME�[IFWMXI��4EXI\ME�LEW�KSRI�XS�KVIEX�PIRKXLW�XS�TVSZMHI�ZEPMH�ERH�EGGYVEXI�EREP]WMW�FEWIH�SR�XLMW�HEXE��,S[IZIV��4EXI\ME�HSIW�RSX�KYEVERXII�����TIVGIRX�EGGYVEG]�RSV�XEOI�ER]�VIWTSRWMFMPMX]�JSV�TSWWMFPI�PSWWIW�GEYWIH�F]�YWI�SJ�MRJSVQEXMSR�TVSZMHIH�MR�XLMW�VITSVX�
9
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Since its inception in September 2012 XLVSYKL�XLI�IRH�SJ�XLI�WIGSRH�UYEVXIV���������-46�TIXMXMSRW�LEZI�FIIR�ƤPIH��8LI�-46�ƤPMRK�EGXMZMX]�JSV�XLI�TIVMSH�SJ�XLMW�WXYH]��.YP]���������XLVSYKL�.YRI��������� �[EW�������[LMGL�WLS[W�E���TIVGIRX�HIGPMRI�GSQTEVIH�XS�XLI�ƤZI�]IEV�TIVMSH�[I�GSZ�IVIH�MR�SYV�XLMVH�ERRYEP�VITSVX�PEWX�]IEV��.YP]���������XLVSYKL�.YRI��������� �
=IEV�SZIV�]IEV�ƤPMRK�TIEOIH�EX�������MR�������7MRGI�XLIR��XLI�-46�ƤPMRK�LEW�FIIR�HIGPMRMRK��-R�������[I�WE[�XLI�PEVKIWX�]IEV�SZIV�]IEV�HIGPMRI�SJ�EVSYRH����TIVGIRX��&YX�EW�[I�LEH�TVIHMGXIH�MR�SYV�PEWX�]IEVŭW�VI�TSVX��MR�XLI�ƤVWX�LEPJ�SJ������[I�WE[�WMKRW�SJ�VIGSZIV]�JSV�FSXL�-46�ERH�HMWXVMGX�GSYVX�TEXIRX�PMXMKEXMSR��;I�ERXMGMTEXI�XLI�ƤPMRK�EGXMZMX]�XS�GSRXMRYI�MXW�KVS[XL�MR������ERH�XLIR�MR������
7IXXPIQIRX�VEXI�LEW�KSRI�YT����TIVGIRX�EKI�TSMRXW��JVSQ����TIVGIRX�MR������XS����TIVGIRX�MR�������1IER[LMPI�XLI�VEXI�SJ�Final Written Decisions�LEW�JEPPIR�EW�QYGL�EW����TIVGIRXEKI�TSMRXW�SZIV�XLI�WEQI�TIVMSH��3ZIVEPP��SYX�SJ�������-46�GEWIW�XLEX�[IVI�GSQTPIXIH�HYVMRK�XLMW�TIVMSH��M�I���WIXXPIH��HIRMIH�SV�VIGIMZIH�*;(�HIGMWMSRW �����TIV�GIRX�HIRMIH�MRWXMXYXMSR�����TIVGIRX�WIXXPIH��ERH����VIGIMZIH�XLI�*MREP�;VMXXIR�(IGMWMSR�
(YVMRK�XLI�ƤZI�]IEV�VITSVXMRK�TIVMSH��E�XSXEP�SJ�������-46W�[IVI�ƤPIH�XS�GLEPPIRKI�������YRMUYI�TEXIRXW�ERH��������YRMUYI�GPEMQW��7S�JEV��XLMW�LEW�VIWYPXIH�MR�MRWXMXYXMSR�ERH�MRZEPMHEXMSR�SJ��������ERH��������GPEMQW��VIWTIGXMZIP]�
-R�XLI�PEWX�ƤZI�]IEVW��������GSQTERMIW�LEZI�FIIR�MRZSPZIH�MR�SRI�SV�QSVI�-46W��8LMW�MRGPYHIW�EFSYX�������TIXMXMSRIVW�ERH�������TEXIRX�S[RIVW��8LI�XST����TIXM�XMSRIVW�EGGSYRX�JSV�EFSYX����TIVGIRX�SJ�EPP�GEWIW��%TTPI�VIQEMRW�XLI�QSWX�EGXMZI�TIXMXMSRIV�[MXL�����-46W��9RMPSG�MW�XLI�QSWX�EGXMZI�TEXIRX�S[RIV�[MXL�����-46W�JSV�XLMW�TIVMSH�
����PE[�ƤVQW�LEZI�VITVIWIRXIH�TEXIRX�S[R�IVW�ERH�TIXMXMSRIVW��*VSQ�XLMW�RYQFIV������ƤVQW�VITVIWIRXIH�TIXMXMSRIVW��[LMPI�����ƤVQW�VITVIWIRXIH�TEXIRX�S[RIVW�MR�SRI�SV�QSVI�GEWIW��WSQI�[IVI�EGXMZI�SR�FSXL�WMHIW ��%�XSXEP�SJ�������EXXSVRI]W�[SVOIH�JSV�XLIWI�ƤVQW��*VSQ�XLMW�RYQFIV��������EXXSVRI]W�VITVIWIRXIH�TIXMXMSRIVW��[LMPI�������EXXSVRI]W�VITVIWIRXIH�TEXIRX�S[RIVW��7MQMPEV�XS�PEWX�]IEV��[I�[MPP�FI�TVSZMHMRK�SYV�PE[�ƤVQ�TEVXRIVW�[MXL�XLI�QSWX�EGXMZI�ERH�FIWX�TIVJSVQMRK�-46�FEHKIW�JSV������
Executive Summary
Appendix
118
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Appendix A
(EXE�MW�XLI�JSYRHEXMSR�ERH�FYMPHMRK�FPSGO�SJ�ER]�HEXE�HVMZIR�EREP]WMW��8LIVIJSVI��GSPPIGX�MRK�HEXE�JVSQ�UYEPMX]�WSYVGIW�ERH�XEOMRK�I\XVE�GEVI�MR�QEMRXEMRMRK�XLI�HEXE�MRXIKVMX]�MW�WSQIXLMRK�[I�EX�4EXI\ME�XEOI�MRXS�EG�GSYRX�ZIV]�WIVMSYWP]��;I�LEZI�GSPPIGXIH�SYV�VE[�HEXE�JVSQ�QER]�WSYVGIW�MRGPYHMRK�
• 4EXIRX�8VMEP�ERH�%TTIEP�&SEVH��48%& �(EXEFEWI
• 9RMXIH�7XEXIW�4EXIRX�ERH�8VEHIQEVO��97483 �4EXIRX�(EXEFEWI
• 4YFPMG�%GGIWW�XS�'SYVX�)PIGXVSRMG�6I�GSVHW��4%')6
• 7IPJ�VITSVXIH�F]�EXXSVRI]W�REQIH�SR�XLI�case
• 97�4EXIRX�'PEWWMƤGEXMSR�(EXEFEWI
*SV�XLMW�VIPIEWI��[I�PMQMXIH�XLI�HEXI�VERKI�SJ�SYV�EREP]WMW�XS�XLI�PEWX�ƤZI�]IEVW��.YP]���������XLVSYKL�.YRI��������� ��
;LMPI�XLI�TSWWMFMPMX]�SJ�IVVSVW�WYGL�EW�X]TSW�MR�PIKEP�HSGYQIRXW�EVI�MRIZMXEFPI��GPIERMRK�ERH�SVKERM^MRK�XLI�EXXSVRI]�HEXE�MW�IZIR�QSVI�GLEPPIRKMRK�EW�EXXSVRI]W�LEZI�WMQMPEV�REQIW��SV�WSQIXMQIW�I\EGXP]�XLI�WEQI�REQIW ��GLERKI�ƤVQW��QE]�RSX�YTHEXI�XLIMV�MRJSVQEXMSR��ERH�SJXIR�YWI�HMJJIVIRX�ZEVME�XMSRW�SJ�XLIMV�REQIW�
3YV�IRKMRIIVMRK�XIEQ�LEW�MQTPIQIRXIH�WSTLMWXMGEXIH�QEGLMRI�PIEVRMRK�ERH�REXYVEP�PERKYEKI�TVSGIWWMRK�XIGLRMUYIW�XS�ƤRH�XLI�GSVVIGX�QEXGLIW�JSV�ZEVMSYW�SGGYVVIRGIW�SJ�XLI�WEQI�REQI��8S�JYVXLIV�QMRMQM^I�XLI�IVVSVW��[I�RSX�SRP]�VIZMI[�WYWTMGMSYW�QEXGLIW�QERYEPP]��FYX�EPWS�LSWX�TVSƤPI�TEKIW�JSV�QSVI�XLER���������EXXSVRI]W�ERH�EKIRXW�[LS�GER�HMVIGXP]�VIZMI[�ERH�EHH�QMWWMRK�GEWIW�XS�SYV�HEXEFEWI��%PP�XLI�YWIV�EHHIH�HEXE�[MPP�EKEMR�FI�ZIVMƤIH�F]�4EXI\ME�MRXIVREP�HEXE�XIEQ�JSV�EGGYVEG]��
Sources of Data
119
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Appendix B
7II�XLI�EXXEGLIH�)\GIP�WTVIEHWLIIX�JSV�XLI�WXEXW�VIPEXIH�XS�YT�XS�������QSWX�EGXMZI�TEXIRX�S[RIVW�ERH�TIXMXMSRIVW��MRZSPZIH�MR�SRI�SV�QSVI�-46�GEWIW��ƤPIH�HYVMRK�XLI�TI�VMSH�SJ�SYV�WXYH]��8LI�WTVIEHWLIIX�GSZIVW�XLI�JSPPS[MRK�MRJSVQEXMSR�JSV�IEGL�SJ�XLI�GSQTERMIW�
��Ʉ'SQTER]�REQI�[MXL�E�PMRO�XS�4EXI\ME�page
��Ʉ%PP�'EWIW��4EXIRX�3[RIV���4IXMXMSRIV
��Ʉ4EXIRX�3[RIV�'EWIW
��Ʉ4IXMXMSRIV�'EWIW
��Ʉ3ZIVEPP�4IVJSVQERGI�6ERO
��Ʉ3ZIVEPP�%GXMZMX]�6ERO
��Ʉ3ZIVEPP�7YGGIWW�6ERO
��Ʉ4EXIRX�3[RIV�4IVJSVQERGI�6ERO
��Ʉ4EXIRX�3[RIV�%GXMZMX]�6ERO
���Ʉ4EXIRX�3[RIV�7YGGIWW�6ERO
���Ʉ4IXMXMSRIV�4IVJSVQERGI�6ERO
���Ʉ4IXMXMSRIV�%GXMZMX]�6ERO
���Ʉ4IXMXMSRIV�7YGGIWW�6ERO
���Ʉ�����3ZIVEPP�4IVJSVQERGI�6ERO
���Ʉ�����3ZIVEPP�%GXMZMX]�6ERO
���Ʉ�����4EXIRX�3[RIV�4IVJSVQERGI�6ERO
���Ʉ�����4EXIRX�3[RIV�%GXMZMX]�6ERO
���Ʉ�����4IXMXMSRIV�4IVJSVQERGI�6ERO
���Ʉ�����4IXMXMSRIV�%GXMZMX]�6ERO
���Ʉ3ZIVEPP�4IVJSVQERGI�7GSVI
���Ʉ4EXIRX�3[RIV�4IVJSVQERGI�7GSVI
���Ʉ4IXMXMSRIV�4IVJSVQERGI�7GSVI
���Ʉ3ZIVEPP�7YGGIWW�7GSVI
���Ʉ4EXIRX�3[RIV�7YGGIWW�7GSVI
���Ʉ4IXMXMSRIV�7YGGIWW�7GSVI
���Ʉ3ZIVEPP�%GXMZMX]�7GSVI
���Ʉ4EXIRX�3[RIV�%GXMZMX]�7GSVI
���Ʉ4IXMXMSRIV�%GXMZMX]�7GSVI
���Ʉ4EXIRX�3[RIV�RSR�TIRHMRK��'SRGPYH�IH �'EWIW
���Ʉ4IXMXMSRIV�RSR�TIRHMRK��'SRGPYHIH �'EWIW
Patent Owners and Petitioners Statistics
120
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Appendix CLaw Firms Statistics
7II�XLI�EXXEGLIH�)\GIP�WTVIEHWLIIX�JSV�XLI�WXEXW�VIPEXIH�XS�EPP�����PE[�ƤVQW��MRZSPZIH�MR�SRI�SV�QSVI�-46�GEWIW��ƤPIH�HYVMRK�XLI�TI�VMSH�SJ�SYV�WXYH]��8LI�WTVIEHWLIIX�GSZIVW�XLI�JSPPS[MRK�MRJSVQEXMSR�JSV�IEGL�SJ�XLI�PE[�ƤVQW�
��Ʉ0E[�ƤVQ�REQI�[MXL�E�PMRO�XS�4EXI\ME�page
��Ʉ%PP�'EWIW��4EXIRX�3[RIV���4IXMXMSRIV
��Ʉ4EXIRX�3[RIV�'EWIW
��Ʉ4IXMXMSRIV�'EWIW
��Ʉ3ZIVEPP�4IVJSVQERGI�6ERO
��Ʉ3ZIVEPP�%GXMZMX]�6ERO
��Ʉ3ZIVEPP�7YGGIWW�6ERO
��Ʉ4EXIRX�3[RIV�4IVJSVQERGI�6ERO
��Ʉ4EXIRX�3[RIV�%GXMZMX]�6ERO
���Ʉ4EXIRX�3[RIV�7YGGIWW�6ERO
���Ʉ4IXMXMSRIV�4IVJSVQERGI�6ERO
���Ʉ4IXMXMSRIV�%GXMZMX]�6ERO
���Ʉ4IXMXMSRIV�7YGGIWW�6ERO
���Ʉ�����3ZIVEPP�4IVJSVQERGI�6ERO
���Ʉ�����3ZIVEPP�%GXMZMX]�6ERO
���Ʉ�����4EXIRX�3[RIV�4IVJSVQERGI�6ERO
���Ʉ�����4EXIRX�3[RIV�%GXMZMX]�6ERO
���Ʉ�����4IXMXMSRIV�4IVJSVQERGI�6ERO
���Ʉ�����4IXMXMSRIV�%GXMZMX]�6ERO
���Ʉ3ZIVEPP�4IVJSVQERGI�7GSVI
���Ʉ4EXIRX�3[RIV�4IVJSVQERGI�7GSVI
���Ʉ4IXMXMSRIV�4IVJSVQERGI�7GSVI
���Ʉ3ZIVEPP�7YGGIWW�7GSVI
���Ʉ4EXIRX�3[RIV�7YGGIWW�7GSVI
���Ʉ4IXMXMSRIV�7YGGIWW�7GSVI
���Ʉ3ZIVEPP�%GXMZMX]�7GSVI
���Ʉ4EXIRX�3[RIV�%GXMZMX]�7GSVI
���Ʉ4IXMXMSRIV�%GXMZMX]�7GSVI
���Ʉ4EXIRX�3[RIV�RSR�TIRHMRK��'SRGPYH�IH �'EWIW
���Ʉ4IXMXMSRIV�RSR�TIRHMRK��'SRGPYHIH �'EWIW
121
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Appendix DAttorneys Statistics
7II�XLI�EXXEGLIH�)\GIP�WTVIEHWLIIX�JSV�XLI�WXEXW�VIPEXIH�XS�XLI�XST������QSWX�EGXMZI�EXXSVRI]W��MRZSPZIH�MR�SRI�SV�QSVI�-46�GEW�IW��ƤPIH�HYVMRK�XLI�TIVMSH�SJ�SYV�WXYH]��8LI�WTVIEHWLIIX�GSZIVW�XLI�JSPPS[MRK�MRJSVQE�XMSR�JSV�IEGL�SJ�XLI�PE[�ƤVQW�
��Ʉ%XXSVRI]�REQI�[MXL�E�PMRO�XS�4EXI\ME�page
��Ʉ0E[�ƤVQ�REQI�[MXL�E�PMRO�XS�4EXI\ME�page
��Ʉ%PP�'EWIW��4EXIRX�3[RIV���4IXMXMSRIV
��Ʉ4EXIRX�3[RIV�'EWIW
��Ʉ4IXMXMSRIV�'EWIW
��Ʉ3ZIVEPP�4IVJSVQERGI�6ERO
��Ʉ3ZIVEPP�%GXMZMX]�6ERO
��Ʉ3ZIVEPP�7YGGIWW�6ERO
��Ʉ4EXIRX�3[RIV�4IVJSVQERGI�6ERO
���Ʉ4EXIRX�3[RIV�%GXMZMX]�6ERO
���Ʉ4EXIRX�3[RIV�7YGGIWW�6ERO
���Ʉ4IXMXMSRIV�4IVJSVQERGI�6ERO
���Ʉ4IXMXMSRIV�%GXMZMX]�6ERO
���Ʉ4IXMXMSRIV�7YGGIWW�6ERO
���Ʉ�����3ZIVEPP�4IVJSVQERGI�6ERO
���Ʉ�����3ZIVEPP�%GXMZMX]�6ERO
���Ʉ�����4EXIRX�3[RIV�4IVJSVQERGI�6ERO
���Ʉ�����4EXIRX�3[RIV�%GXMZMX]�6ERO
���Ʉ�����4IXMXMSRIV�4IVJSVQERGI�6ERO
���Ʉ�����4IXMXMSRIV�%GXMZMX]�6ERO
���Ʉ3ZIVEPP�4IVJSVQERGI�7GSVI
���Ʉ4EXIRX�3[RIV�4IVJSVQERGI�7GSVI
���Ʉ4IXMXMSRIV�4IVJSVQERGI�7GSVI
���Ʉ3ZIVEPP�7YGGIWW�7GSVI
���Ʉ4EXIRX�3[RIV�7YGGIWW�7GSVI
���Ʉ4IXMXMSRIV�7YGGIWW�7GSVI
���Ʉ3ZIVEPP�%GXMZMX]�7GSVI
���Ʉ4EXIRX�3[RIV�%GXMZMX]�7GSVI
���Ʉ4IXMXMSRIV�%GXMZMX]�7GSVI
���Ʉ4EXIRX�3[RIV�RSR�TIRHMRK��'SRGPYH�IH �'EWIW
���Ʉ4IXMXMSRIV�RSR�TIRHMRK��'SRGPYHIH �'EWIW
122
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Appendix E
8LI�JSPPS[MRK�UYIWXMSRW�[IVI�HIWMKRIH�XS�LIPT�YW�IWXMQEXI�XLI�GSWX�ERH�[SVOPSEH�MR�HMJJIVIRX�WXEKIW�SJ�ER�-46�GEWI��
;I�YRHIVWXERH�XLEX�XLI�GSWX�IWXMQEXMSR�MW�RSX�WMQTPI�ERH�MW�E�JYRGXMSR�SJ�QER]�JEGXSVW�MRGPYHMRK�XLI�TEVX]��TIXMXMSRIV�ZW��TEXIRX�S[RIV ��RYQFIV�SJ�TEXIRXW�ERH�HI�JIRHERXW�MRZSPZIH�MR�XLI�HMWXVMGX�GSYVX�GEWI��MJ�XLIVI�MW�E�GEWI ��WXVEXIK]��GSQTPI\MX]��IXG�
*SV�WMQTPMGMX]��[I�SRP]�GSRWMHIVIH�XLMW�JVSQ�XLI�TIXMXMSRIVŭW�TIVWTIGXMZI�ERH�HMZMHI�XLI�TVSGIWW�MRXS�XLI�JSPPS[MRK���TLEWIW�
• 4LEWI����4EXIRX�ERH�4VMSV�%VX�6IZMI[
• 4LEWI����(VEJX�ERH�ƤPI�-46�TIXMXMSR�ERH�SRI�I\TIVX�HIGPEVEXMSR
• 4LEWI����)ZEPYEXI�XLI�TEXIRX�S[RIVŭW�preliminary response
• 4LEWI����)ZEPYEXI�&SEVHŭW�MRWXMXYXMSR�HIGMWMSR��HVEJX�ERH�ƤPI�IZMHIRXMEV]�SFNIG�XMSRW�EW�RIGIWWEV]��TVITEVI�XLI�I\TIVX�
JSV�HITSWMXMSR��HIJIRH�XLI�I\TIVX�MR�XLI�HITSWMXMSR��ERH�VIWTSRWIW�ERH�QSXMSRW�EW�RIGIWWEV]�HYVMRK�TEXIRX�S[RIVŭW�HMWGSZIV]�TIVMSH
• 4LEWI����)ZEPYEXI�XLI�TEXIRX�S[RIVŭW�VI�WTSRWI�ERH�I\TIVX�HIGPEVEXMSR��HVEJX�ERH�ƤPI�IZMHIRXMEV]�SFNIGXMSRW�EW�RIGIWWEV]��XEOI�XLI�HITSWMXMSR�SJ�TEXIRX�S[RIVŭW�I\TIVX��ERH�VIWTSRWIW�ERH�QSXMSRW�EW�RIGIWWEV]�HYVMRK�TIXMXMSRIVŭW�HMWGSZIV]�TIVMSH
• 4LEWI����(VEJX�ERH�ƤPI�TIXMXMSRIVŭW�VITP]�ERH�WYTTPIQIRXEP�I\TIVX�HIGPEVEXMSR��HVEJX�ERH�ƤPI�QSXMSR�XS�I\GPYHI�IZM�HIRGI�EW�RIGIWWEV]
• 4LEWI����4VITEVI�JSV�ERH�GSRHYGX�XLI�oral hearing
• 4LEWI����)ZEPYEXI�ƤREP�[VMXXIR�HIGMWMSR�ERH�HVEJX�ERH�ƤPI�VIUYIWX�JSV�VILIEVMRK�as necessary
• 4LEWI����%TTIEP�*MPI�ERH�GSRHYGX�ET�TIEP�XS�*IHIVEP�'MVGYMX
Survey Questions
123
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
��Ʉ,S[�SJXIR�HS�]SY�QEREKI�ER�-46�TVSNIGX�YRHIV�E�Ƥ\IH�SV�GETTIH�JII�WXVYGXYVI#
• 2IZIV
• %FSYX����SJ�XLI�XMQI
• %FSYX����SJ�XLI�XMQI
• %FSYX����SJ�XLI�XMQI
• %PP�XLI�XMQI
��ɄWhich technology area covers a considerable area of your IPR projects?
• )PIGXVMGEP�ERH�,EVH[EVI
• 7SJX[EVI�ERH�-RXIVRIX
• 1IGLERMGEP
• 4LEVQE�ERH�PMJI�7GMIRGIW
• Other
��ɄWhat is your estimated attorney fee for Phase 0 - Patent and Prior Art Review?
• 0IWW�XLER���/
• &IX[IIR���/�XS����/
• &IX[IIR����/�XS����/
• 1SVI�XLER����/
��Ʉ;LEX�MW�]SYV�IWXMQEXIH�EXXSVRI]�JII�JSV�4LEWI�����(VEJX�ERH�ƤPI�-46�TIXMXMSR�ERH�SRI�expert declaration?
• 0IWW�XLER����/
• &IX[IIR����/�XS����/
• &IX[IIR����/�XS�����/
• 1SVI�XLER�����/
��ɄWhat is your estimated attorney fee for Phase 2 - Evaluate patent owner’s prelimi-nary response?
• 0IWW�XLER�������
• &IX[IIR��������XS�������
• &IX[IIR��������XS��������
• 1SVI�XLER����/
Questions
124
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
��ɄWhat is your estimated attorney fee for Phase 3 - Evaluate Board’s institution deci-WMSR��HVEJX�ERH�ƤPI�IZMHIRXMEV]�SFNIGXMSRW�EW�RIGIWWEV]��TVITEVI�XLI�I\TIVX�JSV�HITS-sition, defend the expert in the deposition, and responses and motions as necessary during patent owner’s discovery period?
• 0IWW�XLER����/
• &IX[IIR����/�XS����/
• 1SVI�XLER����/
��ɄWhat is your estimated attorney fee for Phase 4 - Evaluate patent owner’s response ERH�I\TIVX�HIGPEVEXMSR��HVEJX�ERH�ƤPI�IZMHIRXMEV]�SFNIGXMSRW�EW�RIGIWWEV]��XEOI�the deposition of patent owner’s expert, and responses and motions as necessary during petitioner’s discovery period?
• 0IWW�XLER����/
• &IX[IIR����/�XS����/
• &IX[IIR����/�XS����/
• 1SVI�XLER����/
��Ʉ;LEX�MW�]SYV�IWXMQEXIH�EXXSVRI]�JII�JSV�4LEWI�����(VEJX�ERH�ƤPI�TIXMXMSRIVŭW�VITP]�ERH�WYTTPIQIRXEP�I\TIVX�HIGPEVEXMSR��HVEJX�ERH�ƤPI�QSXMSR�XS�I\GPYHI�IZMHIRGI�EW�necessary?
• 0IWW�XLER����/
• &IX[IIR����/�XS����/
• &IX[IIR����/�XS����/
• &IX[IIR����/�XS����/
• 1SVI�XLER����/
��ɄWhat is your estimated attorney fee for Phase 6 - Prepare for and conduct oral hear-ing?
• 0IWW�XLER����/
• &IX[IIR����/�XS����/
• &IX[IIR����/�XS����/
• 1SVI�XLER����/
125
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
���Ʉ;LEX�MW�]SYV�IWXMQEXIH�EXXSVRI]�JII�JSV�4LEWI�����)ZEPYEXI�ƤREP�[VMXXIR�HIGMWMSR�ERH�HVEJX�ERH�ƤPI�VIUYIWX�JSV�VILIEVMRK�EW�RIGIWWEV]#
• 0IWW�XLER���/
• &IX[IIR���/�XS����/
• &IX[IIR����/�XS����/
• 1SVI�XLER����/
���ɄWhat is your estimated attorney fee for Phase 8 - Appeal File and conduct appeal to Federal Circuit?
• 0IWW�XLER����/
• &IX[IIR����/�XS�����/
• &IX[IIR�����/�XS�����/
• &IX[IIR�����/�XS�����/
• 1SVI�XLER�����/
���ɄDoes the IPR cost change by the number of independent grounds of invalidity in-cluded in the IPR? For example, an IPR that tries to invalidate Claim 1 in one ground is less costly than arguing two separate grounds.
• =IW��HIƤRMXIP]��%VKYMRK�QYPXMTPI�WIT�EVEXI�KVSYRHW�SJ�MRZEPMHMX]�[MPP�GSWX�more
• 2S��RSX�EX�EPP��8LI�GSWX�MW�RSX�E�JYRGXMSR�SJ�RYQFIV�SJ�KVSYRHW�SJ�MRZEPMHMX]
���ɄIs there any discount provided if there are more than one patent from the same family?
• 2S�HMWGSYRX
• 0IWW�XLER���
• &IX[IIR����XS���
• 1SVI�XLER���
���ɄWhat is the estimated cost of Experts?
• 0IWW�XLER����/
• &IX[IIR����/�XS����/
• &IX[IIR����/�XS����/
• &IX[IIR����/�XS����/
• 1SVI�XLER����/
126
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
���ɄWhat is the average hourly rate for your IPR associates?
• 0IWW�XLER������ER�LSYV
• &IX[IIR������XS������ER�LSYV
• &IX[IIR������XS������ER�LSYV
• &IX[IIR������XS������ER�LSYV
• 1SVI�XLER�����
���ɄWhat is the average hourly rate for your IPR partners?
• 0IWW�XLER������ER�LSYV
• &IX[IIR������XS������ER�LSYV
• &IX[IIR������XS��������ER�LSYV
• &IX[IIR��������XS��������ER�LSYV
• 1SVI�XLER�������
���ɄAny additional comments on cost and workload?
7XEJƤRK
;I�YRHIVWXERH�XLEX�PE[�ƤVQW�EPPSGEXI�XLIMV�VIWSYVGIW�HMJJIVIRXP]��-R�XIVQW�SJ�WXEJƤRK��
LS[�QER]�TEVXRIVW�ERH�EWWSGMEXIW�EVI�EW�WMKRIH�XS�E�X]TMGEP�-46�GEWI�F]�]SYV�ƤVQ�
���ɄFor partners:
���
���ɄFor associates:
���
���Ʉ,S[�[SYPH�XLI�WXEJƤRK�FI�EJJIGXIH�SR�XLI�TIXMXMSRIV�WMHI��MJ�XLI�RYQFIV�SJ�TEXIRXW�grows to 5 (how many more partners or associates are needed)?
���Ʉ%R]�EHHMXMSREP�GSQQIRXW�SR�WXEJƤRK#
127
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Performance Measurement
8LI�JSPPS[MRK�UYIWXMSRW�[MPP�LIPT�YW�GEP�GYPEXI�XLI�TSMRXW�JSV�IEGL�WMHI��TIXMXMSRIV�
ERH�TEXIRX�S[RIVW �YRHIV�HMJJIVIRX�GMVGYQ�WXERGIW�
���ɄHow should we allocate the points for settled cases?
Background: For the last three years, we assumed a settled case is a victory for the petition-IV��;LMPI�XLMW�MW�RSX�EP[E]W�XLI�GEWI��[I�FIPMIZI�XLEX�MR�XLI�QENSVMX]�SJ�GEWIW��[LIR�ER�-46�MW�settled, it is a sign that the petitioner’s prior art was strong and the patent owner decided to WIXXPI�VEXLIV�XLER�GSRXMRYMRK�XLI�ƤKLX�ERH�FYVRMRK�QSVI�GEWL�
• ��JSV�XLI�TEXIRX�S[RIV�ERH�����JSV�XLI�TIXMXMSRIV��WMQMPEV�XS�PEWX�]IEVW
• ���JSV�XLI�TEXIRX�S[RIV�ERH����JSV�the petitioner
• ���JSV�XLI�TEXIRX�S[RIV�ERH����JSV�the petitioner
• 2SRI�SJ�XLI�EFSZI��TPIEWI�I\TPEMR
���ɄShould we give extra weight to attorneys with higher activity?
&EGOKVSYRH��*SV�XLI�PEWX�XLVII�]IEVW��[I�LEH�E�GYX�SJJ�RYQFIV��I�K���E�QMRMQYQ�SJ����GSR-GPYHIH�GEWIW�MR�ƤZI�]IEVW ��3RP]�EXXSVRI]W�SV�ƤVQW�[MXL�QSVI�GEWIW�XLER�XLI�XLVIWLSPH�[IVI�MRGPYHIH�MR�XLI�VEROMRKW��&YX�SRGI�MRGPYHIH��[I�XVIEXIH�IZIV]FSH]�XLI�WEQI�
We are considering to change our performance score function to a weighted function which XEOIW�MRXS�EGGSYRX�XLI�EGXMZMX]��8LEX�QIERW�LEZMRK�E�LMKLIV�EGXMZMX]�MR�KIRIVEP��GER�LEZI�WSQI�TSWMXMZI�[IMKLX�SR�XLI�TIVJSVQERGI�WGSVI�
• -�EKVII�XLEX�QSVI�EGXMZMX]�WLSYPH�MQTVSZI�XLI�TIVJSVQERGI
• %GXMZMX]�LEW�RSXLMRK�XS�HS�[MXL�XLI�TIVJSVQERGI�ERH�MX�WLSYPH�RSX�MQ�TEGX�XLI�TIVJSVQERGI
���ɄYour work Email address (optional):
���ɄAny additional comments (other challenges, suggestions, ...)
128
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Contact Us*SYRHIH�MR������XS�FVMRK�IJƤGMIRG]�ERH�XVERWTEVIRG]�XS�MRXIPPIGXYEP�TVSTIVX]�F]�PIZIVEKMRK�XLI�TS[IV�SJ�HEXE��XIGLRSPSK]�ERH�I\TIVXW��4EXI\ME�MW�XLI�PEVKIWX�RIX[SVO�JSV�-4�TVSJIWWMSREPW�[MXL�SZIV���������-4�EXXSVRI]�TVSƤPIW��;I�SJJIV�-4�WIVZMGIW�
YRHIV�JSYV�HMWXMRGX�EVQW��4EXI\ME�'SRRIGX��VIGVYMXMRK ��4EXI\ME�'SRXIWX��GVS[HWSYVG�MRK ��4EXI\ME�6IWIEVGL��-4�HEXEFEWIW ��ERH�4EXI\ME�-RWMKLXW��-4�VITSVXW ��'SRXEGX�YW�XSHE]�XS�PIEVR�QSVI�
(424) 239-9714 [email protected]
DISCLAIMER: The data for this report was obtained from public sources including USPTO, PTAB, and PACER, as well as WIPJ�VITSVXIH�F]�EXXSVRI]W�SR�4EXI\MEŭW�[IFWMXI��4EXI\ME�LEW�KSRI�XS�KVIEX�PIRKXLW�XS�TVSZMHI�ZEPMH�ERH�EGGYVEXI�EREP]WMW�FEWIH�SR�XLMW�HEXE��,S[IZIV��4EXI\ME�HSIW�RSX�KYEVERXII�����TIVGIRX�EGGYVEG]�RSV�XEOI�ER]�VIWTSRWMFMPMX]�JSV�TSWWMFPI�PSWWIW�GEYWIH�F]�YWI�SJ�MRJSVQEXMSR�TVSZMHIH�MR�XLMW�VITSVX�
THE FINE PRINT
8LMW�VITSVX�MW�FIMRK�JYVRMWLIH�TYVWYERX�XS��ERH�MW�WYFNIGX�XS��XLI�8IVQW�SJ�7IVZMGI�SJ�4EXI\ME��-2'���Ű4EXI\MEű �JSYRH�EXLXXTW���[[[�TEXI\ME�GSQ�XIVQWCSJCWIVZMGI�LXQP��EW�XLI�WEQI�QE]�FI�QSHMƤIH�JVSQ�XMQI�XS�XMQI��XLI�Ű8IVQW�SJ�7IVZMGIű �ERH�XLI�XIVQW�WIX�JSVXL�FIPS[�
The report and the information, text, statistics, data, material and graphics (the “Content”) in the report are protected by GST]VMKLX��=SY�QE]�RSX�VIQSZI�XLI�GST]VMKLX�RSXMGI�JVSQ�XLI�VITSVX��=SY�EVI�JVII�XS�WLEVI�XLI�VITSVX�[MXLMR�XLI�SVKERM^EXMSR�XLEX�TYVGLEWIH�XLMW�VITSVX��=SY�QE]�RSX�SXLIV[MWI�QSHMJ]��GST]��VITVSHYGI��TYFPMWL��TSWX��XVERWQMX��WLEVI�SV�HMWXVMFYXI�XLI�VITSVX�SV�ER]�EWTIGX�SJ�XLI�'SRXIRX�[MXLSYX�XLI�TVMSV�[VMXXIR�TIVQMWWMSR�SJ�4EXI\ME��TVSZMHIH��LS[IZIV��XLEX�MJ�]SYV�SVKERM^E-tion is ranked in the report, you may accurately publish and share with third parties the fact of the numerical ranking of your SVKERM^EXMSR�MR�XLI�VITSVX�
%PP�WEPIW�SJ�VITSVXW�EVI�ƤREP��=SY�QE]�RSX�VIXYVR�E�VITSVX�JSV�E�VIJYRH�SRGI�LEZI�TEMH�JSV�XLI�VITSVX�
129
IPR Intelligence Report — September 2020
Copyright ©2020 Patexia Inc. All Rights Reserved.
Patexia. Insights
Thank you for your purchase of the 2020 IPR Intelligence Report. -X�MW�]SYV�WYTTSVX�XLEX�IREFPIW�YW�XS�WTIRH�XLI�XMQI��QSRI]�ERH�TVIGMSYW�XLSYWERHW�SJ�LSYVW�RIIHIH�XS�GSQTMPI�ER�ERRYEP�VITSVX�SJ�XLMW�QEK�
RMXYHI��;I�EX�4EXI\ME�WMRGIVIP]�LSTI�XLMW�VITSVX�FVMRKW�ZEPYI�XS�]SYV�SVKERM^EXMSR�ERH�[I�[IPGSQI�ER]�XLSYKLXW�SV�JIIHFEGO�]SY�QE]�LEZI�
Our Products
Insights;I�LEZI�E�ZMWMSR�SJ�GLERKMRK�XLI�[E]�MR�[LMGL�SYV�GPMIRXW�ZMI[�-4��YWMRK�YRFMEWIH�HEXE�HVMZIR�VEROMRKW��MRHITIRHIRX�QEVOIX�MRXIPPMKIRGI�ERH�MR�HITXL�EREP]WMW�XS�VI�MQEKMRI�XLI�MRHYWXV]�EW�[I�ORS[�MX��.SMR�XLI�KVS[MRK�PMWX�SJ�PE[�ƤVQW�ERH�GSVTSVEXI�GPM�IRXW�[LS�XVYWX�SYV�VIWIEVGL�ERH�VITSVXMRK�
Connect Recruiting and Expert Services0IZIVEKI�XLI�TS[IV�SJ�SYV�RIX[SVO�SJ���������-4�4VSJIWWMSREPW�XS�ƤRH�]SYV�RI\X�PEXIVEP�SV�GSRWYPXMRK�STTSVXYRMX]��'ERŭX�ƤRH�XLI�VMKLX�I\TIVX#�+MZI�YW�E�GEPP�
Contests;IŭVI�EFPI�XS�TVSZMHI�GSQTPI\�-4�HYI�HMPMKIRGI��[LIVI�4EXIRX�4SVXJSPMS�%REP]WMW�MW�NYWX�XLI�FIKMRRMRK��)RNS]�VSFYWX�GVS[H�WSYVGIH�TVMSV�EVX�ERH�IZMHIRGI�SJ�YWI�WIEVGLIW�YWMRK�SYV�GSRXIRX�TPEXJSVQ��
Research9�7��4EXIRXW��%TTPMGEXMSRW��0E[WYMXW��8LI�PMWX�KSIW�SR��[MXL�SRI�SZIVEVGLMRK�QMWWMSR�SJ�XYVRMRK�GSRZIRXMSREPP]�JVYWXVEXMRK�XEWOW�MRXS�WIEQPIWW��ƥE[PIWW�TVSGIWWIW�[MXL�TS[IVJYP�ZMWYEPM^EXMSRW�
*SV�UYIWXMSRW�SV�MRUYMVMIW�VIPEXIH�XS�ER]�SJ�SYV�SJJIVMRKW�TPIEWI�GSRXEGX�YW��EXMRJS$TEXI\ME�GSQ�SV��������������SV�ZMWMX�YW�EX�[[[�TEXI\ME�GSQ
'SZIV�MQEKI�F]�1EXX�6MGI���9VP��LXXTW���GSQQSRW�[MOMQIHME�SVK�[MOM�*MPI�97C4EXIRXC3JƤGI�NTK���8LI�ƤPI�MW�PMGIRWIH�YRHIV�XLI�'VIEXMZI�'SQQSRW�%XXVMFYXMSR�7LEVI�%PMOI�����-RXIVREXMSREP�PMGIRWI�